Pharsight

Am Regent patents expiration

1. Injectafer patents expiration

INJECTAFER's oppositions filed in EPO
INJECTAFER Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11590097 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(21 days from now)

US11291645 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(21 days from now)

US11123321 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(21 days from now)

US9376505 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(21 days from now)

US7612109 AM REGENT Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
Feb, 2024

(4 months from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11478502 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US11364260 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US11433091 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US8895612 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US7754702 AM REGENT Methods and compositions for administration of iron
Feb, 2028

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication (I) May 31, 2026
New Patient Population (NPP) Nov 19, 2024
New Strength (NS) Apr 28, 2024

Drugs and Companies using FERRIC CARBOXYMALTOSE ingredient

Market Authorisation Date: 25 July, 2013

Treatment: Method to treat ida in adults with intolerance or unsatisfactory response to oral iron & heavy uterine bleeding or gi disorder weighing at least 40 kg by administering iv ferric carboxymaltose to give...

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of INJECTAFER before it's drug patent expiration?
More Information on Dosage

INJECTAFER family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic